Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Results from the TRIUMPH-1 trial, presented at the American Diabetes Association Scientific Sessions, show potential for retatrutide, an investigational GIP, GLP-1, and glucagon triple hormone receptor agonist, for treating obesity
Less fluid means less flushing of the urinary tract, giving bacteria more of a chance to settle in
However, regulatory approval is still pending, and further long-term data are required
Michael Brandwein Sep 9, 2025 6 min read Updated: Nov 16, 2025 Key Takeaways Same ingredient, different approvals Both Zepbound and Mounjaro contain tirzepatide, but Zepbound is FDA-approved for chronic weight management, while Mounjaro is approved for type 2 diabetes
Physiology, Immune Response
US$ 28.13
US$ 25.35
US$ 28.02
US$ 20.70
